We also found significant associations between calprotectin and disease status in RA and PsA patients treated with TNFi, with calprotectin levels stratifying disease activity more accurately than CRP and ESR in patients with low levels of inflammation [47]. The gene discussed is ESR1; the disease is rheumatoid arthritis.